4//SEC Filing
Ahlberg Gregory A 4
Accession 0001415889-21-005270
CIK 0000001800other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 6:11 PM ET
Size
14.4 KB
Accession
0001415889-21-005270
Insider Transaction Report
Form 4
Ahlberg Gregory A
Senior Vice President
Transactions
- Exercise/Conversion
Common shares without par value
2021-11-15$48.98/sh+6,000$293,880→ 19,825 total - Sale
Common shares without par value
2021-11-15$130.00/sh−3,905$507,650→ 15,920 total - Exercise/Conversion
Common shares without par value
2021-11-15$59.94/sh+30,935$1,854,244→ 46,855 total - Exercise/Conversion
Option (right to buy)
2021-11-15−30,935→ 15,468 totalExercise: $59.94From: 2021-02-16Exp: 2028-02-15→ Common Shares (30,935 underlying) - Sale
Common shares without par value
2021-11-15$130.00/sh−21,568$2,803,840→ 25,287 total - Exercise/Conversion
Option (right to buy)
2021-11-15−6,000→ 0 totalExercise: $48.98From: 2020-08-14Exp: 2027-08-13→ Common Shares (6,000 underlying)
Holdings
- 10,746(indirect: By Trust)
Common shares without par value
Footnotes (2)
- [F1]Balance in the Abbott Laboratories Stock Retirement Trust as of November 15, 2021.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001826317
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 6:11 PM ET
- Size
- 14.4 KB